Company Profile

Sharps Technology Stock Price, News & Analysis

Ticker:
STSS
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

1.84 USD (+1.10%)

Close

Last updated: May 27, 2026

77.9M USD

Market cap

Why the stock is moving

Current closing-price context is not available for STSS.

Company overview

Business overview

Sharps Technology is a medical device company focused on safer syringes and drug-delivery safety products. Its business is built around reducing contamination and improving handling in injectable workflows.

Geographic Base and Sector Classification

Sharps Technology is headquartered in the United States and listed on NASDAQ. It sits in medical devices and drug-delivery hardware rather than biotechnology.

Business Model Characteristics

The company depends on product adoption, regulatory progress, and the ability to scale its device platform into healthcare channels. Investors watch sales execution and manufacturing readiness.

Position Within the Biotechnology Landscape

Sharps Technology is part of the medical-device safety layer of healthcare. It is not biotech, but it matters to the injection and drug-delivery ecosystem.

Future catalysts

Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling. The market will care about real commercial demand.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Sharps Technology (STSS)?

    Sharps Technology (STSS) most recently closed at 1.84 USD, a +1.10% move versus the previous session.

    What is the market cap of Sharps Technology (STSS)?

    Sharps Technology currently has a market capitalization of 77.9M USD on BioPharmSignal.

    What does Sharps Technology do?

    Sharps Technology is a medical device company focused on safer syringes and drug-delivery safety products. Its business is built around reducing contamination and improving handling in injectable workflows.

    On which exchange is STSS stock listed?

    Sharps Technology (STSS) is associated with NASDAQ, United States, Biopharma.

    What is Sharps?

    Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling.

    Which conditions is Sharps Technology targeting with Sharps?

    Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling.

    How does Sharps Technology describe recent progress with Sharps?

    Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling.

    What is Technology?

    Sharps Technology is a medical device company focused on safer syringes and drug-delivery safety products.